About Verily
Verily is a company based in Dallas (United States) founded in 2015 by Andrew Conrad and Jessica Mega. Verily has raised $2.8 billion across 6 funding rounds from investors including Swiss Re, Temasek and The Michael J. Fox Foundation. Verily has completed 1 acquisition, including SignalPath. Verily offers products and services including Verily Platform, Workbench, Numetric, Lightpath, and Sightline. Verily operates in a competitive market with competitors including Medidata, IQVIA, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter Dallas, United States
- Founders Andrew Conrad, Jessica Mega
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Verily Life Sciences Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.8 B (USD)
in 6 rounds
-
Latest Funding Round
$300 M (USD), Series D
Mar 20, 2026
-
Investors
Swiss Re
& 7 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Verily
Verily offers a comprehensive portfolio of products and services, including Verily Platform, Workbench, Numetric, Lightpath, and Sightline.
Harmonizes healthcare data for AI applications and research workflows
Secure platform for collaborative multimodal data analysis
Tools for precision measurement in medical discoveries
AI-powered care for individuals with chronic conditions
Solutions for monitoring population-level diseases
People of Verily
Unlock access to complete
Unlock access to complete
Product Management Team
44 people
Sales and Marketing
29 people
Software Development Team
28 people
Creative and Marketing Team
22 people
Data Analysis and Operations Team
20 people
Senior Team
15 people
Leadership Team
14 people
Operations Team
11 people
Unlock access to complete
Funding Insights of Verily
Verily has successfully raised a total of $2.8B across 6 strategic funding rounds. The most recent funding activity was a Series D round of $300 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Verily
Verily has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Swiss Re, Temasek and The Michael J. Fox Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
Technology investing and private equity firm focused on partnerships.
|
Locked | Locked | Locked | |
|
Research for Parkinson's disease is funded by the foundation.
|
Locked | Locked | Locked |
Investor details for Verily
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Verily
Verily has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SignalPath.
Investment portfolio details for Verily
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cloud-based software solutions for clinical research sites are provided.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Verily
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Verily
Detailed financials for Verily
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Verily Comparisons
Peer comparison for Verily
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Verily
Verily operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, IQVIA, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
Detailed competitors of Verily
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Verily
Complete news archive for Verily
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verily
Verily was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Verily is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Stephen GillettG is the current CEO of Verily.
Verily is a funded company, having raised a total of $2.8B across 6 funding rounds to date.
Verily was founded in 2015 and is headquartered in Dallas, United States. Operations center on AI-driven technologies and data science within the healthcare sector. Secure access and analysis of medical data are enabled to support treatment development. Chronic health management and hospital patient solutions are offered, alongside devices such as sensor-based wearables and miniaturized continuous glucose monitors.
Verily's top competitors include Medidata, IQVIA and Memora Health.
Verily offers Verily Platform, Workbench, Numetric, Lightpath, and Sightline.
Verily has made 1 acquisition, including SignalPath.
Verily has 8 investors. Key investors include Swiss Re, Temasek, The Michael J. Fox Foundation, Ontario Teachers' Pension Plan, and Silver Lake.